Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

david_horn_solomon

Akari CEO resigns over allegations of spending company funds

May 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akari, appointment

Akari has lost its second CEO in 12 months after David Horn Solomon was accused of misusing the company credit …
Appointment

Janssen’s Tremfya gets go-ahead from NICE in plaque psoriasis

May 11, 2018 Medical Communications, Sales and Marketing Janssen, NICE, Tremfya, UK, pharma, psoriasis

NICE, the UK’s drug watchdog for the NHS, has decided that Janssen’s Tremfya (guselkumab) should be used routinely through the …
News
top_ten

Top Ten most popular articles on Pharmafile.com this week

May 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, EMA, GSK, J&J, JJ, Novartis, Shire, Takeda, Valeant, biotech, drugs, pharma, pharmaceutical

It’s been a week in which one of the largest pharmaceutical takeovers in history took place and yet it’s not …
News
andy_c4

C4 Therapeutics fills out C-Suite with CEO appointment

May 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing C4 Therapeutics, biotech, drugs, pharma, pharmaceutical

C4 Therapeutics has been slowly expanding since its creation in early 2016 out of the prestigious Dana-Farber Cancer Institute. Andrew …
Appointment
lilly2_web

Lilly moves quickly to secure $1.6bn buyout of Armo

May 10, 2018 Medical Communications, Sales and Marketing Armo Biosciences, Eli Lilly, biotech, drugs, pharma, pharmaceutical

Armo BioSciences only went public in January but it has already been snapped up by Eli Lilly for $1.6 billion. …
News
cancer-vs-alzheimer-1080x810

NanoBots: The science of small to dwarf the disease

May 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Precision Medicine, nanorobots, pharma

Anjali Shukla delves into the exciting, miniature world of nanorobotics to explore how the ground-breaking technology promises to change the …
Feature
320px-human_embryonic_stem_cells_only_a

FDA launches lawsuits against stem cell clinics after patients rendered blind

May 10, 2018 Medical Communications, Sales and Marketing FDA, Stem cells, US, macular degeneration, pharma

At the request of the FDA, The US Department of Justice has launched legal action seeking to shut down stem …
News
soil-3301161_960_720

Lodo and Roche go digging for drug candidates, after $1bn deal

May 10, 2018 Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical

Discovering potential therapeutics from natural sources has been a constant throughout the evolution of medicine, Lodo Therapeutics, however, has taken …
News
pharmafile_srping_2018_cover

The new and improved Spring 2018 edition of Pharmafile is available to read online now!

May 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CNS, Cancer, Pharmafocus, cardiovascular, cvd, oncology, pharmafile

The Spring 2018 edition of Pharmafile, our long-running bi-annual guide to the latest trends, projections and thought leadership positions in …
News
joanna_shields

BenevolentAI names former UK Minister as new Group CEO

May 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, BenevolentAI, Facebook, UK, appointment, google

Health and drug development-focused artificial intelligence firm BenevolentAI has announced that former UK Minister for Internet Security and Safety Joanna …
Appointment
credit_-_daniel_leal-olivas-afp

European approval for tablet formulation of Lynparza in ovarian cancer

May 8, 2018 Research and Development, Sales and Marketing AstraZeneca, Cancer, EMA, Europe, MSD, lynparza, ovarian cancer, pharma

AstraZeneca and MSD’s poly ADP-ribose polymerase (PARP) inhibitor Lynparza (olaparib) has been approved for use in Europe, it has emerged, …
News
eye

All eyes on dry eye disease

May 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing TopiVert, dry eye disease, eye, pharma

Dr Matthew Fyfe, Head of Chemistry and Intellectual Property at TopiVert, gives an illuminating look into the latest developments in …
Feature
novartis_side_building

FDA approves Novartis combo in rare thyroid cancer subtype

May 8, 2018 Manufacturing and Production, Sales and Marketing Cancer, FDA, Tafinlar, mekinist, thyroid cancer

The FDA has announced its decision to approve the use of Novartis’ combination of Tafinlar (dabrafenib) and Mekinist (trametinib) in …
News
jj

J&J’s ketamine-based antidepressant showed mixed success at Phase 3

May 8, 2018 Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, Ketamine, antidepressant, depression, esketamine, pharma

Johnson & Johnson has revealed new data on its new depression drug esketamine, its chemically ‘left-handed’ version of the controlled …
News

Genmab and Janssen’s Darzalex combo scores FDA approval in multiple myeloma

May 8, 2018 Manufacturing and Production, Sales and Marketing FDA, Genmab, Janssen, US, darzalex, multiple myeloma, pharma

Genmab and Janssen have revealed that their combination of Darzalex (daratumumab) with bortezomib (Velcade), melphalan, and prednisone (VMP) has received …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026